Radioembolization of the spleen: A revisited approach for the treatment of malignant lymphomatous splenomegaly

CardioVascular and Interventional Radiology

Volumn 36, Issue 4, 2013, Pages 1155-1160

  Muylle, Kristoff ^a,b   Nguyen, Jasmine ^a   De Wind, Alexandre ^a   Meuleman, Nathalie ^a   Delatte, Philippe ^c   Vanderlinden, Bruno ^a   Roelandts, Martine ^a   Van Der Stappen, Anja ^a   Bron, Dominique ^a   Flamen, Patrick ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c Department of Interventional Radiology   (Belgium)

Author keywords

Lymphoma; Radioembolization; Spleen; Splenomegaly

Indexed keywords

BENDAMUSTINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; MACROSALB TC 99M; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISONE; RITUXIMAB; VINCRISTINE; YTTRIUM 90;

ABDOMINAL PAIN; ABNORMAL LABORATORY RESULT; AGED; ANAPHYLACTIC SHOCK; ANEMIA; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; CLINICAL FEATURE; DEATH; HUMAN; HYPERLEUKOCYTOSIS; HYPERSPLENISM; INTENSIVE CARE UNIT; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOCYTOSIS; LYMPHOCYTE; LYMPHOMA; MALE; MARGINAL ZONE LYMPHOMA; PRIORITY JOURNAL; PROSTATITIS; RADIOEMBOLIZATION; RADIOTHERAPY; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; BIOPSY, NEEDLE; DISEASE PROGRESSION; EMBOLIZATION, THERAPEUTIC; FATAL OUTCOME; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; MICROSPHERES; MULTIMODAL IMAGING; RADIATION DOSAGE; RADIOPHARMACEUTICALS; SPLEEN; SPLENECTOMY; SPLENOMEGALY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; YTTRIUM RADIOISOTOPES;

EID: 84879904735     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-012-0484-z     Document Type: Article

References (16)

1. Kennedy A, Nag S, Salem R et al (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68:13-23
2. Gates VL, Atassi B, Lewandowski RJ et al (2007) Radioembolization with yttrium-90 microspheres: review of an emerging treatment for liver tumors. Future Oncol 3:73-81
3. Lewandowski RJ, Sato KT, Atassi B et al (2007) Radioembolization with yttrium-90 microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 30:571-592
4. Swerdlow SH, Campo E, Harris NL et al (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. World Health Organization, Geneva
5. Bennett M, Schechter GP (2010) Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab. Semin Hematol 47:143-147
6. Brown JR, Friedberg JW, Feng Y et al (2009) A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. Br J Haematol 145:741-748
7. Mohrbacher A (2005) B cell non-Hodgkin's lymphoma: rituximab safety experience. Arthr Res Ther 7(Suppl 3):S19-S25
8. Weber DA et al (1989) MIRD: radionuclide data and decay schemes. Society of Nuclear Medicine, New York
9. Ariel IM, Padula G (1973) Irradiation of the spleen by the intra-arterial administration of 90 yttrium microspheres in patients with malignant lymphoma. A preliminary rep Cancer 31:90-96
10. Becker CD, Rösler H, Biasiutti FD, Baer HU (1995) Congestive hypersplenism: treatment by means of radioembolization of the spleen with Y-90. Radiology 195:183-186
11. Kahl BS, Bartlett NL, Leonard JP et al (2010) Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a multicenter study. Cancer 116:106-114
12. Cullingford GL, Watkins DN, Watts AD, Mallon DF (1991) Severe late postsplenectomy infection. Br J Surg 78:716-721
13. Maddison FE (1973) Embolic therapy of hypersplenism. Invest Radiol 8:280-281
14. Spigos DG, Jonasson O, Mozes M, Capek V (1979) Partial splenic embolization in the treatment of hypersplenism. Am J Roentgenol 132:777-782
15. Madoff DC, Denys A, Wallace MJ et al (2005) Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications. Radiographics 25(Suppl 1):S191-S211
16. Bilbao JI, de Martino A, de Luis E et al (2009) Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings. Cardiovasc Intervent Radiol 32:727-736